RPRX as of Oct 31 · 13:44 ET

RPRXNasdaqPharmaceutical Preparations

Royalty Pharma plc · Brief

Next report

4 days

Nov 4 · before openconfirmedQ3 FY26

Earnings

Expected move

Inputs

±1.3%implied · report alone

66.3268.04

straddle ±5.4%

spot 67.18exp Nov 20ATM strike 67.5ATM straddle 4.28IV 33%

Oct 30 closereport share · term structurethin chain

Expected move

Inputs

Implied vs realized

8 reportsHistory

—≥ implied

Jan 10 '25—▲+12.56%—

Feb 11 '25—▲+1.67%—

May 8 '25—▲+1.07%—

Aug 6 '25—▼−2.08%—

Q3 FY25—▲+6.82%—

Feb 11 '26—▲+0.09%—

Q1 FY26—▲+0.56%—

Q2 FY26±5.4%▲+0.47%×0.09

quarterimplied−15%0+15%realized×

Q2 FY26±5.4%▲+0.47%×0.09

Q1 FY26—▲+0.56%—

Feb '26—▲+0.09%—

Q3 FY25—▲+6.82%—

Aug '25—▼−2.08%—

May '25—▲+1.07%—

2 older reports

Feb '25—▲+1.67%—

Jan '25—▲+12.56%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · confirmed

Bull2

2customers disclosing RPRX as a supplierSEC filings

648managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

7 of 24largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

44managers holding the majority of reported value13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

RPRX report session

Customers 1

BIIBBiogen×0.47

× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 21impliedImplied move: ±6.5% into Nov 4 earnings (Oct 21 close).Source

Oct 9report dateEarnings date confirmed: Nov 4, before open.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.